MAVS and ovarian carcinoma: In the MAVS-positive expression group, the Notch pathway, Hh pathway, and Wnt pathway were upregulated, which have been demonstrated to be related to chemotherapy resistance in ovarian cancer (Khalaf et al., 2021).